Enterococcus faecium
Enterococcus faecium is a species of Gram-positive bacteria that is part of the genus Enterococcus. It is a commensal organism, meaning it normally lives harmlessly in the gut of humans and other animals. However, it can cause serious infections, particularly in people with weakened immune systems.
Characteristics[edit]
Enterococcus faecium is a facultative anaerobe, which means it can grow with or without oxygen. It is also halotolerant, meaning it can tolerate high salt concentrations. These characteristics allow it to survive in a variety of environments.
Pathogenicity[edit]
While Enterococcus faecium is normally harmless, it can cause serious infections if it enters the bloodstream or other normally sterile parts of the body. These infections can include endocarditis, bacteremia, and urinary tract infections. Enterococcus faecium is particularly concerning because it is often resistant to many antibiotics, including vancomycin, a last-resort antibiotic for many types of infections.
Antibiotic resistance[edit]
Enterococcus faecium is one of the leading causes of hospital-acquired infections, in part because of its resistance to many antibiotics. This resistance is due to a variety of mechanisms, including the production of beta-lactamase, an enzyme that breaks down certain antibiotics, and the ability to pump out antibiotics that enter the cell.
Treatment[edit]
Treatment of Enterococcus faecium infections can be challenging due to the organism's antibiotic resistance. However, some antibiotics, such as linezolid and daptomycin, are usually effective. In severe cases, combination therapy with multiple antibiotics may be necessary.
Prevention[edit]
Preventing Enterococcus faecium infections involves good hygiene practices, particularly in healthcare settings. This includes hand hygiene, cleaning and disinfecting surfaces, and isolating patients with Enterococcus faecium infections to prevent the spread of the organism.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
